Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report date:
2012

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
adopted in 1997
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N-[4-(2,4-dihydroxyphenyl)-1,3-thiazol-2-yl]-2-methylpropanamide
EC Number:
807-621-3
Cas Number:
1428450-95-6
Molecular formula:
C13H14N2O3S
IUPAC Name:
N-[4-(2,4-dihydroxyphenyl)-1,3-thiazol-2-yl]-2-methylpropanamide
Test material form:
solid: particulate/powder

Method

Target gene:
his operon
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9) prepared from the livers of Aroclor 1254-induced rats
Test concentrations with justification for top dose:
Experiment 1: 5, 15.81, 50, 158.1, 500, 1581 and 5000 µg/plate with and without metabolic activation
Experiment 2: for strains TA98 and TA1535: 20.48, 51.2, 128, 320, 800 and 2000 µg/plate with and without metabolic activation; for strains TA100, TA102 and TA1537: 8.192, 20.48, 51.2, 128, 320 and 800 µg/plate with and without metabolic activation
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Preliminary solubility data indicated that the test substance was soluble in DMSO at concentrations of at least 100 mg/mL.
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
benzo(a)pyrene
mitomycin C
other: 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION:
Experiment 1: in agar (plate incorporation)
Experiment 2: preincubation

DURATION
- Preincubation period: 20 min
- Exposure duration: 72 h

NUMBER OF REPLICATIONS: two separate experiments using triplicate plates with and without metabolic activation

DETERMINATION OF CYTOTOXICITY
- Method: clearing of background lawn
Evaluation criteria:
The test substance was considered positive in this assay if all of the following criteria were met:
- When assessed using Dunnett's test, an increase in revertant numbers gave a significant response (p ≤ 0.01) which was concentration related.
- The positive trend/effects described above were reproducible.
Statistics:
Dunnett's test was used to compare the counts at each concentration with the control.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
True negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Precipitation of the test substance was observed in both experiments at 2000 µg/plate and above.

COMPARISON WITH HISTORICAL CONTROL DATA: All negative controls were in the range of the historical control data.

ADDITIONAL INFORMATION ON CYTOTOXICITY: Cytotoxic effects of the test substance were observed in all tester strains, starting for TA102 and TA1537 at 320 µg/plate with metabolic activation and 500 µg/plate without metabolic activation, for TA100 at 500 µg/plate with and without metabolic activation and for TA98 and TA1535 at 800 µg/plate with metabolic activation and 1581 µg/plate without metabolic activation. The cytotoxic effects ranged from slight diminution of the back ground lawn to complete extermination of the test bacteria at higher concentrations.

Any other information on results incl. tables

Table 1. Test results of experiment 1 (plate incorporation).

Bacterial Reverse Mutation Assay, mean revertants colonies/plate ± standard deviation

EXPERIMENT 1 (plate incorporation)

S9-Mix

Without

 

Test item (µg/plate)

T98

TA100

TA1535

TA1537

TA102

DMSO

23.8 ± 6.1

94.8 ± 3.6

14.0 ± 4.1

6.0 ± 2.5

275.4 ± 33.5

5

24.0 ± 7.0

103.7 ± 7.6

13.3 ± 3.1

6.7 ± 2.5

276.7 ± 11.7

15.81

20.3 ± 4.5

102.3 ± 4.0

16.3 ± 2.5

6.3 ± 2.5

280.3 ± 34.3

50

19.7 ± 1.2

80.0 ± 6.0

22.0 ± 5.0 *

7.3 ± 1.5

275.3 ± 10.3

158.1

19.3 ± 3.8

84.7 ± 8.5

16.0 ± 4.6

7.3 ± 2.9

270.7 ± 11.0

500

16.3 ± 4.5

80.3 ± 5.5 S

15.7 ± 4.5

4.7 ± 0.6 S

217.7 ± 35.2 S

1581

5.3 ± 3.5 S

T

5.0 ± 1.0 V

T

T

5000

P, T

P, T

P, T

P, T

P, T

2NF

905.0 ± 37.0

---

---

---

---

NaN3

---

614.3 ± 58.6

549.7 ± 82.0

---

---

AAC

---

---

---

158.7 ± 31.2

---

MMC

---

---

---

---

850.3 ± 133.3

S9-Mix

 

With

Test item (µg/plate)

TA98

TA100

TA1535

TA1537

TA102

DMSO

30.4 ± 7.6

98.6 ± 9.0

18.0 ± 5.0

13.2 ± 5.0

251.6 ± 10.1

5

34.7 ± 5.1

110.3 ± 10.8

19.3 ± 4.9

18.7 ± 4.7

237.7 ± 14.4

15.81

43.0 ± 11.3

113.7 ± 5.5

16.7 ± 3.1

17.0 ± 6.1

254.0 ± 14.7

50

36.7 ± 2.5

106.7 ± 11.7

21.0 ± 9.5

16.0 ± 1.0

247.0 ± 13.1

158.1

39.0 ± 9.2

93.7 ± 12.4

19.0 ± 2.0

13.0 ± 2.6

228.7 ± 21.1

500

26.0 ± 5.3

73.7 ± 12.7 S

11.7 ± 2.9

8.3 ± 4.0 S

181.3 ± 23.2 S

1581

15.0 ± 2.6 S

T

5.3 ± 4.0 V

T

T

5000

P, T

P, T

P, T

P, T

P, T

BaP

297.7 ± 110.2

---

---

---

---

AAN

---

1081.7 ± 192.8

265.7 ± 3.8

198.3 ± 24.4

1387.3 ± 79.5

P: precipitation of the test substance observed

S: slight thinning of background bacterial lawn

V: very thin background bacterial lawn

T: toxic, no revertant colonies

 

Positive controls:

2NF = 2-nitrofluorene

NaN3 = sodium azide

AAC = 9-aminoacridine

MMC = Mitomycin C

BaP = benzo[a]pyrene

AAN = 2-aminoanthracene

* p<0.05

Table 2. Test results of experiment 2 (pre-incubation).

Bacterial Reverse Mutation Assay, mean revertants colonies/plate ± standard deviation

EXPERIMENT 2 (pre-incubation)

S9-Mix

Without

 

Test item (µg/plate)

T98

TA100

TA1535

TA1537

TA102

DMSO

22.2 ± 5.2

94.8 ± 14.6

17.6 ± 2.9

11.2 ± 4.2

233.4 ± 12.6

8.192

---

94.7 ± 14.0

---

10.0 ± 4.0

243.3 ± 8.1

20.48

24.3 ± 8.1

70.7 ± 8.7

22.7 ± 6.8

9.7 ± 3.5

236.7 ± 4.6

51.2

16.7 ± 4.9

87.7 ± 5.8

14.7 ± 5.8

9.0 ± 2.6

221.3 ± 0.6

128

20.3 ± 2.3

96.3 ± 17.2

16.0 ± 2.6

8.0 ± 3.6

201.0 ± 22.1

320

20.3 ± 3.2

87.0 ± 9.8

11.7 ± 3.8

10.3 ± 4.5

180.7 ± 15.0

800

10.3 ± 2.5

47.3 ± 6.7

11.3 ± 4.7

4.7 ± 1.5

102.7 ± 5.7 V

2000

5.3 ± 2.1 P, V

---

2.3 ± 0.6 P, V

---

---

2NF

735.7 ± 87.9

---

---

---

---

NaN3

---

671.7 ± 94.0

686.7 ± 24.1

---

---

AAC

---

---

---

100.3 ± 34.8

---

MMC

---

---

---

---

715.0 ± 99.3

S9-Mix

 

With

Test item (µg/plate)

TA98

TA100

TA1535

TA1537

TA102

DMSO

33.8 ± 6.1

120.0 ± 9.9

20.6 ± 4.5

17.0 ± 4.0

225.2 ± 23.6

8.192

---

114.0 ± 18.5

---

19.3 ± 1.5

261.3 ± 11.6 *

20.48

39.3 ± 4.7

112.7 ± 7.5

15.7 ± 0.6

18.7 ± 2.5

249.0 ± 15.6

51.2

39.0 ± 7.5

126.7 ± 14.0

17.7 ± 5.5

16.7 ± 1.2

259.0 ± 15.6 *

128

32.3 ± 6.7

125.7 ± 7.4

16.3 ± 3.5

21.0 ± 3.0

232.7 ± 13.7

320

28.3 ± 5.9

119.0 ± 5.6

12.7 ± 2.5

19.3 ± 0.6 S

229.7 ± 2.3 S

800

15.0 ± 3.5 S

T

2.3 ± 0.6 V

T

T

2000

P, T

---

P, T

---

---

BaP

339.0 ± 28.2

---

---

---

---

AAN

---

1414.7 ± 33.5

257.7 ± 10.4

260.0 ± 13.9

942.3 ± 199.4

P: precipitation of the test substance observed

S: slight thinning of background bacterial lawn

V: very thin background bacterial lawn

T: toxic, no revertant colonies

 

Positive controls:

2NF = 2-nitrofluorene

NaN3 = sodium azide

AAC = 9-aminoacridine

MMC = Mitomycin C

BaP = benzo[a]pyrene

AAN = 2-aminoanthracene

* p<0.05

Applicant's summary and conclusion

Conclusions:
It was concluded that W630 (Sample ID: 26480) did not induce mutation in five
histidine-requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of
Salmonella typhimurium when tested under the conditions of this study. These
conditions included treatments at concentrations up to 5000 μg/plate (the maximum
recommended concentration according to current regulatory guidelines) or toxic
concentrations, in the absence and in the presence of a rat liver metabolic activation
system (S-9).
Executive summary:

W630 (Sample ID: 26480) was assayed for mutation in five histidine-requiring strains

(TA98, TA100, TA1535, TA1537 and TA102) of Salmonella typhimurium, both in

the absence and in the presence of metabolic activation by an Aroclor 1254-induced

rat liver post-mitochondrial fraction (S-9), in two separate experiments.

All W630 (Sample ID: 26480) treatments in this study were performed using

formulations prepared in anhydrous analytical grade dimethyl sulphoxide (DMSO).

Experiment 1 treatments of all the tester strains were performed in the absence and in

the presence of S-9, using final concentrations of W630 (Sample ID: 26480) at 5,

15.81, 50, 158.1, 500, 1581 and 5000 μg/plate, plus negative (vehicle) and positive

controls. Following these treatments, evidence of toxicity was observed at 500 and/or

1581 μg/plate and above in all strains in the absence and presence of S-9.

Experiment 2 treatments of all the tester strains were performed in the absence and in

the presence of S-9. For strains TA98 and TA1535, the maximum test concentration

was reduced to 2000 μg/plate and for strains TA100, TA1537 and TA102 the

maximum test concentration was reduced to 800 μg/plate, based on toxicity observed

in Experiment 1. Narrowed concentration intervals were employed covering the

ranges 20.48 – 2000 μg/plate or 8.192 – 800 μg/plate respectively, in order to

examine more closely those concentrations of W630 (Sample ID: 26480) approaching

the maximum test concentration. In addition, all treatments in the presence of S-9

were further modified by the inclusion of a pre-incubation step. Following these

treatments, evidence of toxicity was observed at 320 μg/plate and above in strain

TA1537 and TA102 in the presence of S-9; 800 μg/plate and above in strain TA98 in

the absence and presence of S-9 and strain TA1535 in the presence of S-9; and 800

and/or 2000 μg/plate in strain TA100 in the absence and presence of S-9, and strains

TA1535, TA1537 and TA102 in the absence of S-9.